James R Berenson, MD
President and CEO – James R. Berenson, M.D., Inc.
Medical & Scientific Director
Institute for Myeloma & Bone Cancer Research (IMBCR)
Chief Executive Officer
Oncotherapeutics
W. Hollywood, CA

Articles

XM Satellite Radio June 2008
Dr. Berenson featured on ReachMD XM Satellite Radio Channel 157 “Multiple Myeloma: Current Treatment Modalities” Free registration required.


I-Newswire.com March 2008
Multiple Myeloma expert, James R. Berenson, MD, featured on free telephone workshop, “Caring for Your Bones When You Have Multiple Myeloma” April 2, 2008.


Patientpower.com November 2007
Hear Dr. Berenson speak on:
Contemporary Issues in Relapsed-Refractory Myeloma

We've been receiving hundreds of questions from myeloma patients. While we can't answer them all, they do tend to cover common ground. We'll address key topics in our next live webcast, the fourth in a series of 7 programs. Join us for our discussion with Dr. James Berenson, Founder, President and CEO of the Institute for Myeloma and Bone Cancer Research.
Replay Available here



IONlink August 2006
A Phase I/II Study of Trisenox®, VELCADE® and Ascorbic Acid in Relapsed/Refractory Multiple Myeloma. Read the article...


Oncology Times August 2006
Zoledronic Acid Extends Survival In Lung Cancer & Multiple Myeloma Patients With High Levels of Bone Metabolism. Read the article...


American Cancer Society November 2005
Safety of Prolonged Therapy with Bortezomib in Relapsed or Refractory Multiple Myeloma Read the article...

 

 

Berenson Oncology
9201 Sunset Blvd., Suite 310
West Hollywood, CA 90069
Tel: 310 623.1222
Fax: 310 623.1122